K

Kangji Medical Holdings Ltd
HKEX:9997

Watchlist Manager
Kangji Medical Holdings Ltd
HKEX:9997
Watchlist
Price: 6.43 HKD 0.94%
Market Cap: 7.6B HKD
Have any thoughts about
Kangji Medical Holdings Ltd?
Write Note

Gross Margin
Kangji Medical Holdings Ltd

79.8%
Current
81%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
79.8%
=
Gross Profit
782.6m
/
Revenue
980.8m

Gross Margin Across Competitors

Country CN
Market Cap 7.8B HKD
Gross Margin
80%
Country JP
Market Cap 6.8T JPY
Gross Margin
86%
Country CH
Market Cap 37.6B CHF
Gross Margin
55%
Country DK
Market Cap 179.6B DKK
Gross Margin
68%
Country US
Market Cap 15.8B USD
Gross Margin
70%
Country CN
Market Cap 51.5B CNY
Gross Margin
72%
Country CA
Market Cap 6.3B USD
Gross Margin
61%
Country KR
Market Cap 9.1T KRW
Gross Margin
15%
Country US
Market Cap 6.2B USD
Gross Margin
65%
Country UK
Market Cap 4.5B GBP
Gross Margin
56%
Country US
Market Cap 5.7B USD
Gross Margin
47%
No Stocks Found

Kangji Medical Holdings Ltd
Glance View

Market Cap
7.8B HKD
Industry
Health Care

Kangji Medical Holdings Ltd., nestled in the bustling backdrop of China's thriving medical device industry, has carved a niche for itself in the realm of minimally invasive surgery (MIS). Since its inception, the company has focused on designing and manufacturing a range of surgical tools and devices that cater specifically to MIS procedures. These procedures, which include general surgery, gynecology, and urology, are gaining popularity due to their reduced recovery times and lower risk factors compared to traditional surgery. Kangji Medical leverages its robust R&D capabilities and intimate understanding of physicians' needs to deliver high-quality, ergonomic instruments that enhance operational precision and patient outcomes. The lifeblood of Kangji Medical lies in its strategic manufacturing and marketing prowess, enabling it to maintain a solid foothold in the competitive landscape. By keeping its production chain streamlined and efficient, the company achieves significant cost advantages, which in turn translates to competitive pricing. These savings are reinvested in expanding its product portfolio and enhancing technological innovations, thus ensuring a constant edge over its peers. Moreover, Kangji's astute distribution networks and partnerships with leading hospitals enable it to secure a steady demand flow for its products. This strategy has not only facilitated steady revenue growth but also ensured Kangji's reputation as a reliable contributor to the advancing field of minimally invasive surgical procedures.

Intrinsic Value
10.32 HKD
Undervaluation 38%
Intrinsic Value
Price
K

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
79.8%
=
Gross Profit
782.6m
/
Revenue
980.8m
What is the Gross Margin of Kangji Medical Holdings Ltd?

Based on Kangji Medical Holdings Ltd's most recent financial statements, the company has Gross Margin of 79.8%.